OrbiMed Capital GP VI LLC
10% Owner

OrbiMed Capital GP VI LLC insider trades: Adicet Bio (ACET) stock buys and sales

10% Owner, Adicet Bio Last trade Apr 8, 2026 99 Form 4 filings
$675K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
82
Open-market trades
since 2017
29
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where OrbiMed Capital GP VI LLC reports to the SEC

and 23 more companies

Open-market buys and sales

82 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 8, 2026ACET↓ Sell$675K
Oct 8, 2025ACET↑ Buy$5.0M
May 14, 2025NPCE↓ Sell$2.7M
Apr 9, 2025CMPX↓ Sell$5.7M
Apr 3, 2025EWTX↑ Buy$10.0M
Mar 24, 2025IRON↓ Sell$310K
Mar 21, 2025IRON↓ Sell$2.8M
Mar 12, 2025IRON↓ Sell$17.0M
Aug 26, 2024SPRY↓ Sell$1.1M
Aug 23, 2024SPRY↓ Sell$11.5M
Aug 13, 2024SCPH↑ Buy$2.0M
Jun 17, 2024IRON↑ Buy$3.0M
May 3, 2024NPCE↓ Sell$409K
Apr 24, 2024NPCE↓ Sell$25K
Apr 23, 2024NPCE↓ Sell$913K
Apr 18, 2024NPCE↓ Sell$238K
Apr 12, 2024NPCE↓ Sell$7.0M
Jan 25, 2024ACET↑ Buy$7.5M
Jan 23, 2024EWTX↑ Buy$5.0M
Dec 28, 2023ALPN↓ Sell$28.7M
Dec 18, 2023IRON↓ Sell$102K
Dec 14, 2023IRON↓ Sell$24.6M
Dec 14, 2023IRON↓ Sell$7.9M
Oct 3, 2023NPCE↓ Sell$75K
Aug 29, 2023SPRY↑ Buy$3.1M
Jul 20, 2023TSBX↑ Buy$5.0M
Jun 27, 2023ACET↑ Buy$1.8M
May 22, 2023PRLD↑ Buy$5.0M
May 15, 2023VRNA↓ Sell$9.9M
Feb 15, 2023IRON↑ Buy$2.5M
Dec 23, 2022VRNA↓ Sell$136.0M
Nov 25, 2022SCPH↑ Buy$4.0M
Sep 16, 2022EWTX↑ Buy$5.0M
Sep 12, 2022SWTX↓ Sell$4.9M
Aug 9, 2022SWTX↓ Sell$10.5M
Jun 24, 2022IKNA↑ Buy$1.1M
May 18, 2022EWTX↑ Buy$995K
Jan 26, 2022ETNB↓ Sell$592K
Sep 17, 2021ALPN↑ Buy$9.5M
Jul 1, 2021SWTX↓ Sell10b5-1$1.4M
Jun 28, 2021SWTX↓ Sell10b5-1$554K
Jun 25, 2021SWTX↓ Sell10b5-1$4.8M
Jun 10, 2021SWTX↓ Sell10b5-1$2.6M
Jun 9, 2021SWTX↓ Sell10b5-1$4.1M
Apr 21, 2021NPCE↑ Buy$4.0M
Mar 30, 2021IKNA↑ Buy$6.8M
Mar 30, 2021EWTX↑ Buy$5.8M
Mar 30, 2021ORIC↓ Sell10b5-1$2.4M
Mar 26, 2021ORIC↓ Sell10b5-1$2.8M
Mar 23, 2021ORIC↓ Sell10b5-1$863K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ACET insiders

Open-market trades in the last 12 months

About OrbiMed Capital GP VI LLC's insider trades

OrbiMed Capital GP VI LLC is a 10% owner of Adicet Bio (ACET). Since Apr 25, 2017, it has reported 44 open-market purchases worth $266.1M and 38 sales worth $432.6M on SEC Form 4. In the last 12 months: 1 sale ($675K).

10 sales (7% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Its filings also include conversions (20 filings), other transactions (9 filings), grants and awards (9 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACET insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.